Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients
Jie Yang, Hefei Li, Ben Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11

Showing 11 citing articles:

Metabolomics and the Multi-Omics View of Cancer
David S. Wishart
Metabolites (2022) Vol. 12, Iss. 2, pp. 154-154
Open Access | Times Cited: 36
Rate of Pathogenic Germline Variants in Patients With Lung Cancer
Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 20
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors
Risa Burr, Ignaty Leshchiner, Christina L. Costantino, et al.
Nature Cancer (2024) Vol. 5, Iss. 11, pp. 1681-1696
Open Access | Times Cited: 4
Germline EGFR mutations in lung cancer (Review)
Minghui Liu, Xiaoyu Niu, Hongyu Liu, et al.
Oncology Letters (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 10
Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes
Weixin Zhao, Ailing Song, Yang Xu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study
Óscar Arrieta, Enrique Caballé‐Perez, Norma Hernández‐Pedro, et al.
Lung Cancer (2024) Vol. 194, pp. 107864-107864
Closed Access | Times Cited: 2
Family Matters: Germline Testing in Thoracic Cancers
Feighanne Hathaway, Renato Martins, Steven Sorscher, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 5
Multiple primary lung cancer: Updates and perspectives
Ziqi Wang, Quncheng Zhang, Chaoyang Wang, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 5, pp. 785-799
Closed Access | Times Cited: 1
Clinical application of liquid biopsy in cancer patients
Chieh‐Min Chang, Kuei-Ching Lin, Nien-En Hsiao, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing
Zhe Yu, Zirui Zhang, Jun Liu, et al.
Molecular Oncology (2023) Vol. 18, Iss. 5, pp. 1301-1315
Open Access | Times Cited: 2
Germline mutations and developmental mosaicism underlyingEGFR-mutant lung cancer
Risa Burr, Ignaty Leshchiner, Christina L. Costantino, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top